Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

US · MD · Bethesda National Institutes of Health (NIH) grant open #PAR-25-039

Response due Sep 07, 2026 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting research grant applications (R01) focused on schizophrenia and related disorders as they manifest during mid- to late-life. This is a Funding Opportunity Announcement (FOA) published on Grants.gov under Program Announcement with Review (PAR-25-039). Clinical trials are optional under this mechanism. The opportunity is open for an extended period, accepting applications from November 2024 through September 2026.

What they want

Applicants are invited to submit R01 research grant proposals addressing schizophrenia and related psychotic disorders in mid- to late-life populations. Clinical trial research is permitted but not required. Specific research priorities, aims, and deliverables would be detailed in the full FOA text on Grants.gov/NIH Guide for Grants and Contracts.

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

Full FOA text not provided — specific eligibility restrictions, study section assignments, or special review criteria cannot be assessed for bias
PAR mechanism (Program Announcement with Special Receipt, Referral, and/or Review) may indicate a targeted review panel that could favor established investigators in this niche area

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Schizophrenia and related disorders during…

Due Sep 07

Onboard ↗